Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferiprone versus placebo for brain iron overload in Parkinson's disease
2008-006842-25Phase 2Active
- Sponsor
- CHU de Lille
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Deferiprone with Placebo (2 arms). Primary endpoint: Mean T2* MRI relaxation time (R2*) in the substantia nigra. Started Mar 2009; status: active.
02
Drugs
deferiprone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2008-006842-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006842-25.